國家衛生研究院 NHRI:Item 3990099045/8679
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 925129      線上人數 : 900
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8679


    題名: Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure
    作者: Liou, BH;Lee, YT;Kuo, SC;Liu, PY;Fung, CP
    貢獻者: Division of Infectious Diseases
    摘要: We described the clinical outcome of 17 patients with secondary Acinetobacter bacteremia, whose isolates had a tigecycline minimal inhibitory concentration of </= 2mg/L and that received tigecycline within 2 days of bacteremia onset. Fourteen-day mortality rate of tigecycline cohort was 41.2% (7/17), which was significantly higher than those receiving other appropriate antimicrobial agents (13.8%, 9/65, P=0.018). However, the percentages of end-stage renal disease and congestive heart failure were higher in the tigecycline cohort. Efficacy of tigecycline was contingent upon the illness severity and bacterial species. Tigecycline should be applied cautiously for treatment of Acinetobacter bacteremia.
    日期: 2015-06
    關聯: Antimicrobial Agents and Chemotherapy. 2015 Jun;59(6):3637-3640.
    Link to: http://dx.doi.org/10.1128/aac.04987-14
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0066-4804&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000358623200093
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84929648571
    顯示於類別:[郭書辰] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB25824230.pdf152KbAdobe PDF327檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋